Sex and Gender Differences in Pulmonary Manifestations of Autoimmune Disease

Muddassir Aliniazee, Marilyn K Glassberg Csete

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Although only 8% of the population develop autoimmune diseases (AD), 78% are women. The pulmonary manifestations range from mild to life-threatening and the severity depends on the AD. In some AD, such as rheumatoid arthritis (RA), gender differences are well recognized. More men develop pulmonary disease in RA, which includes interstitial lung disease, rheumatoid nodules, and pleural effusions. In scleroderma, 40-80% of patients develop pulmonary complications that contribute to the high mortality rate. Sjögren's syndrome has a low mortality rate and rarely involves the lungs. This chapter focuses on the literature available on sex hormone differences in the pulmonary manifestations of RA, scleroderma, and the association of Raynaud's phenomenon. Women appear to have increased susceptibility to most AD, excluding RA. The available clinical data are minimal and support further research and clinical studies to define the role of hormones in the lung and their role in AD.

Original languageEnglish
Title of host publicationPrinciples of Gender-Specific Medicine
PublisherElsevier Inc.
Pages277-285
Number of pages9
ISBN (Print)9780123742711
DOIs
StatePublished - Dec 1 2010

Fingerprint

Sex Characteristics
Autoimmune Diseases
Rheumatoid Arthritis
Lung
Rheumatoid Nodule
Raynaud Disease
Mortality
Interstitial Lung Diseases
Gonadal Steroid Hormones
Pleural Effusion
Lung Diseases
Hormones
Research
Population

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Sex and Gender Differences in Pulmonary Manifestations of Autoimmune Disease. / Aliniazee, Muddassir; Glassberg Csete, Marilyn K.

Principles of Gender-Specific Medicine. Elsevier Inc., 2010. p. 277-285.

Research output: Chapter in Book/Report/Conference proceedingChapter

Aliniazee, Muddassir ; Glassberg Csete, Marilyn K. / Sex and Gender Differences in Pulmonary Manifestations of Autoimmune Disease. Principles of Gender-Specific Medicine. Elsevier Inc., 2010. pp. 277-285
@inbook{0b14936151fb47c9a4f3dc24039b9316,
title = "Sex and Gender Differences in Pulmonary Manifestations of Autoimmune Disease",
abstract = "Although only 8{\%} of the population develop autoimmune diseases (AD), 78{\%} are women. The pulmonary manifestations range from mild to life-threatening and the severity depends on the AD. In some AD, such as rheumatoid arthritis (RA), gender differences are well recognized. More men develop pulmonary disease in RA, which includes interstitial lung disease, rheumatoid nodules, and pleural effusions. In scleroderma, 40-80{\%} of patients develop pulmonary complications that contribute to the high mortality rate. Sj{\"o}gren's syndrome has a low mortality rate and rarely involves the lungs. This chapter focuses on the literature available on sex hormone differences in the pulmonary manifestations of RA, scleroderma, and the association of Raynaud's phenomenon. Women appear to have increased susceptibility to most AD, excluding RA. The available clinical data are minimal and support further research and clinical studies to define the role of hormones in the lung and their role in AD.",
author = "Muddassir Aliniazee and {Glassberg Csete}, {Marilyn K}",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-374271-1.00025-3",
language = "English",
isbn = "9780123742711",
pages = "277--285",
booktitle = "Principles of Gender-Specific Medicine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Sex and Gender Differences in Pulmonary Manifestations of Autoimmune Disease

AU - Aliniazee, Muddassir

AU - Glassberg Csete, Marilyn K

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Although only 8% of the population develop autoimmune diseases (AD), 78% are women. The pulmonary manifestations range from mild to life-threatening and the severity depends on the AD. In some AD, such as rheumatoid arthritis (RA), gender differences are well recognized. More men develop pulmonary disease in RA, which includes interstitial lung disease, rheumatoid nodules, and pleural effusions. In scleroderma, 40-80% of patients develop pulmonary complications that contribute to the high mortality rate. Sjögren's syndrome has a low mortality rate and rarely involves the lungs. This chapter focuses on the literature available on sex hormone differences in the pulmonary manifestations of RA, scleroderma, and the association of Raynaud's phenomenon. Women appear to have increased susceptibility to most AD, excluding RA. The available clinical data are minimal and support further research and clinical studies to define the role of hormones in the lung and their role in AD.

AB - Although only 8% of the population develop autoimmune diseases (AD), 78% are women. The pulmonary manifestations range from mild to life-threatening and the severity depends on the AD. In some AD, such as rheumatoid arthritis (RA), gender differences are well recognized. More men develop pulmonary disease in RA, which includes interstitial lung disease, rheumatoid nodules, and pleural effusions. In scleroderma, 40-80% of patients develop pulmonary complications that contribute to the high mortality rate. Sjögren's syndrome has a low mortality rate and rarely involves the lungs. This chapter focuses on the literature available on sex hormone differences in the pulmonary manifestations of RA, scleroderma, and the association of Raynaud's phenomenon. Women appear to have increased susceptibility to most AD, excluding RA. The available clinical data are minimal and support further research and clinical studies to define the role of hormones in the lung and their role in AD.

UR - http://www.scopus.com/inward/record.url?scp=84882462787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882462787&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374271-1.00025-3

DO - 10.1016/B978-0-12-374271-1.00025-3

M3 - Chapter

SN - 9780123742711

SP - 277

EP - 285

BT - Principles of Gender-Specific Medicine

PB - Elsevier Inc.

ER -